netFormulary NHS
Milton Keynes Formulary
Milton Keynes University Hospital NHS Foundation Trust
Milton Keynes Clinical Commissioning Group
Milton Keynes Community Health Services
 Search
 Formulary Chapter 3: Respiratory system - Full Section
Notes:

Patient Counselling Resource

RightBreathe: www.rightbreathe.com

  • RightBreathe is a new website and application about inhaler devices launched on 20th February 2017. It has significant MI input and collaboration between multidisciplinary healthcare professionals.
  • RightBreathe covers each and every inhaler and spacer device licensed in the UK for treating asthma and COPD. It presents specific, tailored information on each option in a standardised format and with assured quality.
  • RightBreathe enables clinicians and patients to search and filter the options to suit individual circumstances and patients’ needs.
 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
03.01 Bronchodilators (0,1)
Asthma (0,0)
Chronic obstructive pulmonary disease (0,0)
Croup (0,0)
03.01.01 Adrenoceptor agonists (0,0)
03.01.01.01 Selective Beta2 agonists (7,6)
Short-acting beta2 agonists (0,0)
Long-acting beta2 agonists (0,0)
03.01.01.02 Other adrenoceptor agonists (1,1)
03.01.02 Antimuscarinic bronchodilators (7,0)
03.01.03 Theophylline (3,0)
03.01.04 Compound bronchodilator preparations (4,2)
03.01.05 Peak flow meters, inhaler devices and nebulisers (2,1)
Peak flow meters (1,6)
Drug delivery devices (2,11)
Nebulisers (0,0)
Nebuliser Diluent (0,0)
03.02 Corticosteroids (15,8)
03.03 Cromoglicate, related therapy and leukotriene receptor antagonists (0,0)
03.03.01 Cromoglicate and related therapy (0,2)
Related therapy (0,0)
03.03.02 Leukotriene receptor antagonists (1,1)
03.03.03 Phosphodiesterase type-4 inhibitors (1,0)
03.04 Antihistamines, hyposensitisation, and allergic emergencies (0,0)
03.04.01 Antihistamines (0,0)
Non-sedating antihistamines (3,6)
Sedating antihistamines (3,5)
03.04.02 Allergen Immunotherapy (5,5)
Omalizumab (1,0)
03.04.03 Allergic emergencies (0,0)
Anaphylaxis (2,3)
Angioedema (0,4)
Intramuscular adrenaline (epinephrine) (0,0)
Intravenous adrenaline (epinephrine) (0,0)
Self-administration of adrenaline (epinephrine) (0,0)
03.05 Respiratory stimulants and pulmonary surfactants (0,0)
03.05.01 Respiratory stimulants (1,0)
03.05.02 Pulmonary surfactants (2,0)
03.06 Oxygen (0,0)
Long-term oxygen therapy (0,0)
Short burst oxygen therpary (0,0)
Ambulatory oxygen therapy (0,0)
Oxygen therapy equipment (0,0)
Arrangements for supplying oxygen (0,0)
03.07 Mucolytics (3,5)
Dornase alfa (0,1)
Hypertonic Sodium Chloride (2,1)
Mannitol (1,0)
03.08 Aromatic inhalations (1,1)
03.09 Cough preparations (0,0)
03.09.01 Cough suppressants (2,3)
Palliative care (0,1)
03.09.02 Expectorant and demulcent cough preparations (1,2)
03.10 Systemic nasal decongestants (1,0)
03.11 Antifibrotics (3,0)
netFormulary